Literature DB >> 32949186

Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction.

Ali Ahmad1, Michel T Corban1, Takumi Toya1,2, Frederik H Verbrugge1,3, Jaskanwal D Sara1, Lilach O Lerman4, Barry A Borlaug1, Amir Lerman1.   

Abstract

AIMS: This study uniquely explored the relationship between coronary microvascular function and exercise haemodynamics using concurrent invasive testing. METHODS AND
RESULTS: Fifty-one consecutive patients with unexplained cardiac exertion symptoms, non-obstructive coronary artery disease and normal left ventricular ejection fraction (>50%) underwent haemodynamic exercise assessment and concurrent coronary reactivity testing. Heart failure with preserved ejection fraction (HFpEF) was defined as a pulmonary arterial wedge pressure (PAWP) ≥15 mmHg at rest and/or ≥25 mmHg at peak exercise. Endothelium-independent coronary microvascular dysfunction (CMD) was defined as a coronary flow reserve (CFR) ≤2.5, while endothelium-dependent CMD was defined as ≤50% increase in coronary blood flow (CBF) in response to intracoronary acetylcholine infusions. Patients with HFpEF (n = 22) had significantly lower CFR (2.5 ± 0.6 vs. 3.2 ± 0.7; P = 0.0003) and median %CBF increase in response to intracoronary acetylcholine [1 (-35; 34) vs. 64 (-4; 133); P = 0.002] compared to patients without HFpEF (n = 29). PAWP was significantly higher in patients with endothelium-independent CMD compared to controls during both rest and exercise. This significant elevation was only present during exercise in patients with endothelium-dependent CMD compared to controls. CFR had significant inverse correlations with PAWP at rest (r = -0.31; P = 0.03) and peak exercise (r = -0.47, P = 0.001). CFR also had positive correlations with maximal exercise capacity (in W/kg) (r = 0.33, P = 0.02).
CONCLUSIONS: Coronary microvascular function is inversely associated with filling pressures, particularly during exercise. Both types of CMD are associated with higher filling pressures at peak exercise. These findings underscore the potential mechanism and therapeutic target for CMD and HFpEF.
© 2020 European Society of Cardiology.

Entities:  

Keywords:  Exercise haemodynamics; Heart failure with preserved ejection fraction; Microvascular dysfunction

Year:  2020        PMID: 32949186     DOI: 10.1002/ejhf.2010

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  16 in total

Review 1.  Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies.

Authors:  Kazunori Omote; Frederik H Verbrugge; Barry A Borlaug
Journal:  Annu Rev Med       Date:  2021-08-11       Impact factor: 13.739

Review 2.  Coronary Microvascular Dysfunction Across the Spectrum of Cardiovascular Diseases: JACC State-of-the-Art Review.

Authors:  Marco Giuseppe Del Buono; Rocco A Montone; Massimiliano Camilli; Salvatore Carbone; Jagat Narula; Carl J Lavie; Giampaolo Niccoli; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2021-09-28       Impact factor: 24.094

Review 3.  Treatment of heart failure with preserved ejection fraction with SGLT2 inhibitors: new therapy standard?

Authors:  Christian A Schneider; Roman Pfister
Journal:  Herz       Date:  2022-08-26       Impact factor: 1.740

4.  The myocardial flow reserve in patients with heart failure with preserved ejection fraction.

Authors:  Andrew V Mochula; Kristina V Kopeva; Alina N Maltseva; Elena V Grakova; Marina Gulya; Andrey V Smorgon; Anna Gusakova; Konstantin V Zavadovsky
Journal:  Heart Vessels       Date:  2022-09-01       Impact factor: 1.814

Review 5.  Assessment and Treatment for Coronary Microvascular Dysfunction by Contrast Enhanced Ultrasound.

Authors:  Junzhen Zhan; Longhe Zhong; Juefei Wu
Journal:  Front Cardiovasc Med       Date:  2022-06-20

Review 6.  Endothelial Autophagy in Coronary Microvascular Dysfunction and Cardiovascular Disease.

Authors:  Fujie Zhao; Ganesh Satyanarayana; Zheng Zhang; Jianli Zhao; Xin-Liang Ma; Yajing Wang
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

7.  Untangling the pathophysiologic link between coronary microvascular dysfunction and heart failure with preserved ejection fraction.

Authors:  Aish Sinha; Haseeb Rahman; Andrew Webb; Ajay M Shah; Divaka Perera
Journal:  Eur Heart J       Date:  2021-11-14       Impact factor: 35.855

Review 8.  Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.

Authors:  Ambarish Pandey; Sanjiv J Shah; Javed Butler; Dean L Kellogg; Gregory D Lewis; Daniel E Forman; Robert J Mentz; Barry A Borlaug; Marc A Simon; Julio A Chirinos; Roger A Fielding; Elena Volpi; Anthony J A Molina; Mark J Haykowsky; Flora Sam; Bret H Goodpaster; Alain G Bertoni; Jamie N Justice; James P White; Jingzhone Ding; Scott L Hummel; Nathan K LeBrasseur; George E Taffet; Iraklis I Pipinos; Dalane Kitzman
Journal:  J Am Coll Cardiol       Date:  2021-09-14       Impact factor: 27.203

9.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17

Review 10.  Endothelium in Coronary Macrovascular and Microvascular Diseases.

Authors:  Shigeo Godo; Jun Takahashi; Satoshi Yasuda; Hiroaki Shimokawa
Journal:  J Cardiovasc Pharmacol       Date:  2021-12-03       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.